AllianceBernstein
FBRX icon

AllianceBernstein’s Forte Biosciences FBRX Stock Holding History

AllianceBernstein’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-34
Closed -$7K – 3150
2019
Q4 		$7K Hold
34
– – ﹤0.01% 3118
2019
Q3 		$9K Hold
34
– – ﹤0.01% 3151
2019
Q2 		$86K Buy
+34
New +$101K ﹤0.01% 3097

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AllianceBernstein's FBRX Position: Q1 2020 in Review

AllianceBernstein sold out of Forte Biosciences (FBRX) in Q1 2020, closing a stake of 34 shares — an estimated $7K sold.

AllianceBernstein first reported a position in FBRX in Q2 2019 and held it in 3 quarters. The position peaked at $86K in Q2 2019. 50 funds tracked by Wall St. Rank hold FBRX as of Q1 2020.

  • AllianceBernstein reported no remaining Forte Biosciences position as of Q1 2020 after selling out during the quarter.
  • AllianceBernstein sold 34 Forte Biosciences shares in Q1 2020, an estimated $7K.
  • AllianceBernstein first reported a position in Forte Biosciences in Q2 2019 and held it in 3 quarters.
  • AllianceBernstein's Forte Biosciences position peaked at $86K in Q2 2019.
  • 50 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2020.

Based on AllianceBernstein's 13F filing for Q1 2020, filed 14 May 2020.